1.51
Nyxoah Sa stock is traded at $1.51, with a volume of 19,453.
It is down -2.24% in the last 24 hours and up +8.93% over the past month.
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
See More
Previous Close:
$1.56
Open:
$1.54
24h Volume:
19,453
Relative Volume:
0.06
Market Cap:
$152.01M
Revenue:
$17.85M
Net Income/Loss:
$-96.93M
P/E Ratio:
-0.6105
EPS:
-2.4735
Net Cash Flow:
$-88.29M
1W Performance:
-7.01%
1M Performance:
+8.93%
6M Performance:
-62.62%
1Y Performance:
-75.56%
Nyxoah Sa Stock (NYXH) Company Profile
Name
Nyxoah Sa
Sector
Industry
Phone
-
Address
-
Compare NYXH vs ISRG, BDX, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
NYXH
Nyxoah Sa
|
1.519 | 164.12M | 17.85M | -96.93M | -88.29M | -2.4735 |
|
ISRG
Intuitive Surgical Inc
|
367.45 | 132.30B | 11.03B | 3.16B | 3.22B | 8.7251 |
|
BDX
Becton Dickinson Co
|
189.47 | 51.11B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
ALC
Alcon Inc
|
71.59 | 35.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
RMD
Resmed Inc
|
236.10 | 32.95B | 5.54B | 1.52B | 1.74B | 10.37 |
|
MDLN
Medline Inc
|
35.68 | 28.58B | 29.14B | 1.07B | 1.05B | 1.1956 |
Nyxoah Sa Stock (NYXH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-31-23 | Initiated | H.C. Wainwright | Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Apr-21-22 | Initiated | Oppenheimer | Outperform |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Dec-21-21 | Resumed | Cantor Fitzgerald | Overweight |
| Jul-28-21 | Initiated | Cantor Fitzgerald | Overweight |
View All
Nyxoah Sa Stock (NYXH) Latest News
Cantor Fitzgerald cuts Nyxoah stock price target on valuation By Investing.com - Investing.com Nigeria
Cantor Fitzgerald cuts Nyxoah stock price target on valuation - Investing.com
Cantor Fitzgerald Issues Pessimistic Forecast for Nyxoah (NASDAQ:NYXH) Stock Price - MarketBeat
NYXH Q2 2026 Earnings: EPS Miss of 46.48% Overshadowed by 2.53% Share GainCapex Guidance - Vinanet
Understanding Momentum Shifts in (NYXH) - Stock Traders Daily
Nyxoah (NASDAQ: NYXH) investors report 11.0M-share, 9.9% beneficial stake - Stock Titan
Nyxoah (NYXH) Q2 2026 Earnings: Wider-than-Expected Loss Flags Cost PressuresQuarterly Profit Report - dars.gov.et
Nyxoah SA (EBR:NYXH) Just Released Its Second-Quarter Earnings: Here's What Analysts Think - webull.com
Wall Street Zen Downgrades Nyxoah (NASDAQ:NYXH) to Sell - MarketBeat
A Quick Look at Today's Ratings for Nyxoah SA(NYXH.US), With a Forecast Between $2.31 to $6 - Moomoo
Nyxoah (NASDAQ:NYXH) Releases Earnings Results, Misses Expectations By $0.20 EPS - MarketBeat
Oppenheimer Adjusts Price Target on Nyxoah to $4 From $13, Maintains Outperform Rating - marketscreener.com
Nyxoah SA Stock 12‑Month Price Target Cut to $6, Implies 326% Upside - TradingView
Nyxoah SA Revenue Breakdown – EURONEXT:NYXH - TradingView
Piper Sandler Maintains Nyxoah SA(NYXH.US) With Buy Rating, Cuts Target Price to $6 - Moomoo
Nyxoah Q2 Earnings Call Highlights - MarketBeat
Nyxoah SA (NYXH) (Q2 2026) Earnings Call Highlights: US Revenue Surges 22% Sequentially, $110M ... - Yahoo Finance
Nyxoah SA reports results for the quarter ended June 30Earnings Summary - TradingView
Nyxoah SA (NYXHB.XD) Q2 FY2026 earnings call transcript - Yahoo Finance
NYXH: Q2 2026 revenue surged 21% sequentially, with strong U.S. growth and robust outlook - TradingView
Nyxoah Reports Second Quarter and First Half 2026 Financial and Operating Results - The Manila Times
Nyxoah (NASDAQ: NYXH) lifts H1 2026 revenue to €14.0M as U.S. launch scales - Stock Titan
Earnings To Watch: Nyxoah SA (XBRU:NYXH) Q2 2026 -- GF Value Sees 5209% Upside - GuruFocus
Avoiding Lag: Real-Time Signals in (NYXH) Movement - Stock Traders Daily
Nyxoah SA (NYXH) Holds at $1.45 as Sleep Apnea MedTech Stock Tests Key Support ZoneSuperTrend Flip - vinanet.vn
Nyxoah SA expected to post a loss of 42 cents a shareEarnings Preview - TradingView
NYXH Q1 2026 Earnings: EPS Beats by 27.03% as Revenue Remains UndisclosedEPS Consistency Score - vinanet.vn
Nyxoah (NYXH) Projected to Release Earnings on Wednesday - MarketBeat
Nyxoah management to discuss Q2 results in Aug. 5 webcast - Stock Titan
Nyxoah SA (NYXH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Nyxoah SA (NYXH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Nyxoah SA (NYXH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Nyxoah to Release Second Quarter 2026 Financial Results on August 5, 2026 - Sahm
Nyxoah SA (NYXH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
NYXH|Nyxoah SA|Price:1.400|Chg%:-0.070 - TradingKey
Nyxoah SA (NYXH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Nyxoah (NYXH) Q1 2026 Earnings: EPS Surprise of 27% Despite Zero Revenue; Shares Dip 4.76%Earnings Beat Alert - po-news-eg.net
Nyxoah SA (NYXH) Cash Flow - TradingKey
Nyxoah SA Revenue Breakdown – FWB:5YI - TradingView
Nyxoah (NYXH) Sinks, Testing Key Support at $1.33Resistance Breakout Stocks - vinanet.vn
Nyxoah (NYXH) Q1 2026 Earnings: EPS Beat Narrowes Losses, Shares Dip as Market Awaits Revenue MilestonesManagement Guidance Update - dars.gov.et
Nyxoah SA (NYXH) Stock Price Quote Today & Current Price Chart | Capital.com Australia - Capital.com
Nyxoah SA Revenue Breakdown – AQUISEU:NYXHB - TradingView
Nyxoah SA (NYXH) Stock Price Quote Today & Current Price Chart - Capital.com
Nyxoah SA (NYXH) Share Price Quote Today & Current Price Chart | Capital.com UK - Capital.com
Nyxoah SA (NYXH) Stock Price Quote Today & Current Price Chart | Capital.com EU - Capital.com
Nyxoah (NYXH) Q1 2026 Earnings: Narrowed Loss Beats Estimates, Shares Dip 4.76%Earnings Deceleration Risk - vinanet.vn
Price to sales forward of Nyxoah SA – EURONEXT:NYXH - TradingView
NYXH Q1 2026 Earnings: Narrower-Than-Expected Loss Fuels Cautious OptimismPost-Announcement Reaction - Vinanet
Discipline and Rules-Based Execution in NYXH Response - Stock Traders Daily
Price to sales forward of Nyxoah SA – FWB:5YI - TradingView
Nyxoah Sa Stock (NYXH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):